A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
Condition(s):Xeroderma PigmentosumLast Updated:September 21, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Xeroderma PigmentosumLast Updated:September 21, 2023Recruiting
Condition(s):Xeroderma PigmentosumLast Updated:June 18, 2023Recruiting
Condition(s):Xeroderma PigmentosumLast Updated:May 14, 2010Unknown status
Condition(s):Kaposi’s DiseaseLast Updated:May 14, 2019Unknown status
Condition(s):Xeroderma PigmentosumLast Updated:July 22, 2020Completed
Condition(s):HIV Infection Associated Kaposi DiseaseLast Updated:August 1, 2014Terminated
Condition(s):Xeroderma Pigmentosum; Basal Cell Carcinoma; Squamous Cell Carcinoma; Melanoma; Skin CancerLast Updated:September 21, 2023Active, not recruiting
Condition(s):Cockayne Syndrome; Skin Neoplasms; Xeroderma Pigmentosum; Trichothiodystrophy Syndromes; GenodermatosisLast Updated:September 11, 2023Recruiting
Condition(s):Skin Cancer; Xeroderma Pigmentosum; Basal Cell Nevus SyndromeLast Updated:September 30, 2009Completed
Condition(s):Precancerous ConditionLast Updated:November 6, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.